Mitchell Shirvan
Vorstandsvorsitzender bei D.H.S Medical Ltd.
Profil
Mitchell Shirvan is currently the Chief Executive Officer at D.H.S Medical Ltd.
He also holds the position of Vice President-Innovation & Discovery at VYNE Pharmaceuticals Ltd.
since 2017.
Previously, he served as the Chief Executive Officer at Macrocure Ltd.
and as the Senior Director-Global Strategic Business at Teva Pharmaceutical Industries Ltd.
Dr. Shirvan holds an MBA from the University of Bradford and a doctorate from The Hebrew University of Jerusalem.
Aktive Positionen von Mitchell Shirvan
| Unternehmen | Position | Beginn |
|---|---|---|
D.H.S Medical Ltd.
 D.H.S Medical Ltd. Packaged SoftwareTechnology Services D.H.S Medical Ltd. develops a platform technology for treating and monitoring heart failure. Its proprietary technology is designed to measure and monitor real time cardiac motion and based on this information to optimize cardiac performance. The company was founded by Guy Dori and Oscar Lichtenstein in 2010 and is headquartered in Nazareth, Israel. | Vorstandsvorsitzender | - |
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Corporate Officer/Principal | 01.08.2017 |
Ehemalige bekannte Positionen von Mitchell Shirvan
| Unternehmen | Position | Ende |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - |
| MACROCURE LTD | Vorstandsvorsitzender | - |
Ausbildung von Mitchell Shirvan
| University of Bradford | Masters Business Admin |
| The Hebrew University of Jerusalem | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
Macrocure Ltd.
 Macrocure Ltd. Medical SpecialtiesHealth Technology Macrocure Ltd. is a clinical-stage biotechnology company, which engages in the development and commercialization of advanced cell therapy products. Its product, CureXcell, is an advanced wound care therapy that treat such wounds by injecting living human white blood cells that have been activate to facilitate the healing process. The company was founded by David Ben-Ami on January 14, 2008 and is headquartered in Petach Tikva, Israel. | Health Technology |
D.H.S Medical Ltd.
D.H.S Medical Ltd. Packaged SoftwareTechnology Services D.H.S Medical Ltd. develops a platform technology for treating and monitoring heart failure. Its proprietary technology is designed to measure and monitor real time cardiac motion and based on this information to optimize cardiac performance. The company was founded by Guy Dori and Oscar Lichtenstein in 2010 and is headquartered in Nazareth, Israel. | Technology Services |
